← TrialMatch
HomeTrials

EMG Analysis in ABI: Motor Imagery and Action

This study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. By measuring muscle activity in the wrist and finger flexors and extensors, the research seeks to understand the impact of MI and AO on mo

Condition(s)Stroke, Quality of Life, Mirror Movement
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis study focuses on electromyographic analysis of upper limb muscle activation in stroke survivors during Motor Imagery (MI) and Action Observation (AO) rehabilitation techniques. By measuring muscle activity in the wrist and finger flexors and extensors, the research seeks to understand the impact of MI and AO on motor function recovery post-stroke. Conducted at the University of Salamanca, the study involves stroke survivors participating in a series of three experimental sessions. The analysis will correlate electromyographic responses with functional independence, limb functionality, and cognitive factors. The research aims to contribute to the fields of occupational therapy and physiotherapy, offering insights into effective rehabilitation methods for improving quality of life in st
Who can participateInclusion Criteria: * Being over 18 years of age * Diagnoses of established stroke * Present limitations or motor response deficiencies in the upper limb * Maintain cognitive functions with the ability to follow the instructions of the interventions and evaluations (MOCA\>14) Exclusion Criteria: * Diagnosed with mental illness before the stroke * Other systemic conditions on the central nervous system * Cardiorespiratory system pathologies in severe cases * Acute period, fever, muscle inflammation or myopathies * Any type of vascular and organic insufficiency * Liver disease or skin lesions in the area of application of the electrodes.
Ages18 Years to 99 Years
SexAll
Lead sponsorUniversity of Salamanca
LocationsSalamanca, Salamanca, Spain
Start date2024-01-01
NCT IDNCT06230718
Official listinghttps://clinicaltrials.gov/study/NCT06230718

🔍 Search all trials →